For instance, in lung cancer, the “mesenchymal” phenotype is associated with distinct TME changes, including the elevation of immune checkpoint molecules and the enhanced tumor infiltration by CD4+Foxp3+ regulatory T cells and CD3+ T cells (36). This evidence concerns the gene CD4 and lung cancer.